Business Type Exporter, Buying House
Location India
Year Established 1981
Main Markets South America 12% Africa 11% Eastern Asia 12% Domestic Market 8% North America 12% Eastern Europe 10% Southern Europe 12% Mid East 11% Northern Europe 8% Oceania 4%
Main Products Isotretinoin,2 KGA, Methanol,Abscisic Acid
Country/Region India
Links
Company Introduction
Nicholas Piramal India Ltd (NPIL) is part of Piramal Enterprise Ltd (PEL). NPIL Pharma buss is US $ 435 and total PEL buss is US $ 750. NPIL rank no.4 in Indian pharma formulation buss. Top 10 dosage form company in domestic indian pharma market in which NPIL has market share of 4.3%. Partners are Allergan, AMO, Boots, Aventis, Biogen, Chiesi. Acquired Rhodia Uk Inhalation anaesthesia - Halothane & Isofurane. Parenterals - Polygeline. Dermatology - Soap Tetmosol ( for Scabies ) brand acquired from AstraZeneca UK. We have Process R&D and Pharma R&D with a team of 65 scientists each in both R&D with around 25,000 xx each area dedicated for both facility. Have OTC range of products which we plan to Export to various countries under our own (NPIL) brand name and willing to make products for Importing customers who wish to take products under their own brand name.
Contact Information
Contact Person Saurabh kapure
Job Title manager
Telephone 91 - 22 - 25378333
Fax Number 91 - 22 - 25413209
Address Mumbai Agra Road Thane W Maharashtra 400608 India
Fax 91 - 22 - 25413209
Website Visit website